CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 18,690
-110 (-0.59%)
May 15, 2026, 12:28 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 103.14 billion as of May 14, 2026. Its market cap has decreased by -19.14% in one year.
Market Cap
103.14B
Enterprise Value
n/a
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,690.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 103.14B, an increase of 916.50%. That is a compound annual growth rate of 10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 103.14B | -7.62% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daihan Pharmaceutical | 167.29B |
| Dongwha Pharm.Co.,Ltd | 167.14B |
| SAMSUNG PHARM. Co., LTD. | 166.59B |
| Kyongbo Pharmaceutical | 151.81B |
| Ilsung Is | 142.52B |
| Jeil Pharma Holdings | 130.33B |
| HANDOK | 123.54B |
| Ildong Holdings | 96.77B |